Bullish option flow detected in Bausch Health (BHC) with 5,026 calls trading, 2x expected, and implied vol increasing over 2 ...

Evercore ISI upgraded shares of Bausch Health Companies (TSE:BHC – Free Report) to a hold rating in a research note published ...

Evercore ISI upgraded shares of Bausch + Lomb (NYSE:BLCO – Free Report) from an in-line rating to an outperform rating in a ...

Bausch Health has recently changed its strategy for Bausch + Lomb, looking to sell the segment which has a market capitalization of nearly $8 billion. The potential sale of Bausch + Lomb is a break ...

The global aesthetic medical device market, valued at USD 13.73 billion in 2024, is set for steady growth over the next ...

MGP Ingredients expects a downbeat third quarter and lowered its full-year outlook, as weak demand and high inventories have hurt the company's whiskey sales. The distilled-spirits and ...

The potential sale of its 88% stake in Bausch + Lomb could generate billions for creditors and shareholders of the indebted ...

During one of the most divisive periods in modern U.S. history, Senate Republicans and Democrats came together to advance legislation that protects America's children. An enduring debate surrounds ...

In a report released yesterday, Larry Biegelsen from Wells Fargo assigned a Buy rating on Bausch + Lomb Corporation (BLCO – Research ...

In a report released today, Umer Raffat from Evercore ISI maintained a Hold rating on Bausch Health Companies (BHC – Research Report).

We are thrilled to welcome Dr. Wechsler to our Board of Directors,” said Dr. Carl Goldfischer, Chair of the Board of Galecto. “Amy is a distinguished physician who has board certification in both ...

After kicking off a sales process roughly a month ago, eye-health firm Bausch + Lomb has stirred up significant interest from ...